QA: Cumberland Pharmaceuticals INC in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001087294_2016_Cumberland_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001087294, Cumberland Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 67,112,074
1 IntangibleAssetsNetIncludingGoodwill 21,168,596
2 PropertyPlantAndEquipmentNet 536,450
3 remainder_Assets 3,101,839
4 LiabilitiesCurrent 12,411,747
5 LiabilitiesNoncurrent 987,429
6 remainder_Liabilities 1,700,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,612,548
9 ResearchAndDevelopmentExpense 3,822,044
10 remainder_Expenses 21,709,331
11 remainder_Revenues 33,712,038
12 remainder_NetIncome 200,254
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 91,918,959
1 Liabilities 15,099,176
2 Expenses 33,143,923
3 Revenues 33,712,038
4 StockholdersEquity 76,819,783
5 NetIncome 768,369
6 ComprehensiveNetIncome 768,369
7 BaseVar 87,037,175
8 EconomicCapitalRatiobeforeLimitedLiability 3.14
9 EconomicCapitalRatio 3.78

Edgar->Model Mapping

Feature Distribution

Change over Time